About this trial
This clinical trial evaluates a community health education intervention (I CAN) for increasing community-driven actions to reduce the cancer burden in Western New York. Engaging community members is a critical component of designing impactful programs to reduce the cancer burden. Leaders at the national, state, and local levels have all called for more community partnerships and engagement in design of health intervention and policies. The I CAN intervention is a workshop that includes a presentation outlining key concepts related to social network processes and the cancer burden in Western New York, a structured skill-building activity, and then empowering and motivating activities meant to cultivate momentum and excitement for action. This community health education intervention may be able to provide a formalized process for empowering and facilitating community members to take steps to reduce the community cancer burden.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being over 18 years old
Able to participate in English
Disqualifiers
Unwilling or unable to follow protocol requirements
Trial design
Single group
Treatments tested in this trial
Community Health Education
Procedure/SurgeryReceive I CAN intervention
Telephone Based Intervention
BehavioralReceive coaching call
Treatment groups
Trial outcomes
Primary outcomes
Demand - Phase 1
Feasibility will be assessed through demand, which will be evaluated as the number of people enrolled and the demographics of participants. Descriptive analyses will be used.
Practicality - Phase 1
Practicality will be assessed through the percentage of participants who complete different aspects of the intervention. Descriptive analyses will be used.
Acceptability- Phase 1
Acceptability will be examined through post-intervention measures, including the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Descriptive analyses will be used.
Lung Cancer Screening Uptake
Will be assessed by determining if I CAN intervention results in higher number of individuals who complete lung cancer screening
Secondary outcomes
Rate of follow up for Lung cancer screening
Other outcomes
Lung Cancer Screening knowledge - Phase 2
Will be compared between arms using an 8 item survey of True/False questions
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Roswell Park Cancer Institute
Lead sponsor
Merck Sharp & Dohme LLC
Collaborator
National Comprehensive Cancer Network
Collaborator